US Regional and Demographic Differences in Prescription Opioid and Heroin-related Overdose Hospitalizations

Overview

Journal Int J Drug Policy

Publisher Elsevier

Specialties Psychiatry
Public Health

Date 2017 Jul 10

PMID 28688539

Citations 65

Authors

George Jay Unick

Daniel Ciccarone

Affiliations

Soon will be listed here.

Abstract

Background: US opioid overdose death rates have increased between 2000 and 2014. While, the increase in prescription opioid use has been linked to the increase in heroin use, there are reasons to view this relationship as a partial explanation for the recent increase in heroin-related harms. This study documents the differences in trends in prescription opioid overdose-related (POD) and heroin overdose-related (HOD) hospitalizations.

Methods: Data come from the National Inpatient Sample (NIS) for the years 2000 through 2014. POD and HOD hospitalizations were abstracted from ICD-9 codes. Rates of POD and HOD by census region and census division were constructed along with separate rates for age and race. Regression analysis analyzing trends across region were estimated along with graphs for documenting differences in POD and HOD rates.

Results: POD hospitalization rates were highest in the South and lowest in the Northeast. HOD hospitalization rates were highest in the Northeast region and grew the fastest in the Midwest. There was statistically significant heterogeneity in HOD trends but not POD trends across the four regions between 2000 and 2014. Between 2012 and 2014 POD rates decreased in eight of the nine census divisions, with only New England showing an increase. HOD hospitalization rates increased in all nine census divisions between 2012 and 2014. Both POD and HOD rates show different demographic patterns across the nine census divisions.

Conclusion: Comparing POD and HOD hospitalization trends reveals significant disparities in geographic as well as demographic distributions. These epidemics are evolving and the simple opioid-to-heroin transition story is both supported and challenged by this paper. The opioid pill, heroin and fentanyl crises are intertwined yet increasingly have drivers and outcomes that support examining them as distinct. Addressing these complex and interrelated epidemics will require innovative public health research and interventions which need to consider local and regional contexts.

Citing Articles

Comparison of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in metropolitan and rural areas of South of Iran.

Zibaeenezhad M, Sayadi M, Pourmontaseri H, Khalili D, Farjam M, Bahramail E Sci Rep. 2025; 15(1):550.

PMID: 39747531 PMC: 11696312. DOI: 10.1038/s41598-024-84366-4.

A state-level history of opioid overdose deaths in the United States: 1999-2021.

Kline D, Hepler S, Krawczyk N, Rivera-Aguirre A, Waller L, Cerda M PLoS One. 2024; 19(9):e0309938.

PMID: 39240938 PMC: 11379184. DOI: 10.1371/journal.pone.0309938.

State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009-2020.

Johnson C, Chrischilles E, Arndt S, Carnahan R J Am Med Inform Assoc. 2024; 31(10):2337-2346.

PMID: 38905012 PMC: 11413439. DOI: 10.1093/jamia/ocae160.

Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.

Bart G, Korthuis P, Donohue J, Hagedorn H, Gustafson D, Bazzi A Addict Sci Clin Pract. 2024; 19(1):29.

PMID: 38600571 PMC: 11007900. DOI: 10.1186/s13722-024-00455-9.

Trends, outcomes, and factors associated with in-hospital opioid overdose following major surgery.

Curry J, Coaston T, Vadlakonda A, Sakowitz S, Mallick S, Chervu N Surg Open Sci. 2024; 18:111-116.

PMID: 38523845 PMC: 10957460. DOI: 10.1016/j.sopen.2024.03.002.

References

Reardon J, Harmon K, Schult G, Staton C, Waller A . Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: A retrospective analysis of a surveillance case definition. BMC Emerg Med. 2016; 16:11. PMC: 4746926. DOI: 10.1186/s12873-016-0075-4. View

Cerda M, Santaella J, Marshall B, Kim J, Martins S . Nonmedical Prescription Opioid Use in Childhood and Early Adolescence Predicts Transitions to Heroin Use in Young Adulthood: A National Study. J Pediatr. 2015; 167(3):605-12.e1-2. PMC: 4714948. DOI: 10.1016/j.jpeds.2015.04.071. View

Compton W, Jones C, Baldwin G . Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med. 2016; 374(2):154-63. PMC: 11784537. DOI: 10.1056/NEJMra1508490. View

Slavova S, Bunn T, Talbert J . Drug overdose surveillance using hospital discharge data. Public Health Rep. 2014; 129(5):437-45. PMC: 4116371. DOI: 10.1177/003335491412900507. View

Rudd R, Seth P, David F, Scholl L . Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(50-51):1445-1452. DOI: 10.15585/mmwr.mm655051e1. View

Jones C . Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013; 132(1-2):95-100. DOI: 10.1016/j.drugalcdep.2013.01.007. View

Grau L, Dasgupta N, Harvey A, Irwin K, Givens A, Kinzly M . Illicit use of opioids: is OxyContin a "gateway drug"?. Am J Addict. 2007; 16(3):166-73. DOI: 10.1080/10550490701375293. View

Frank R, Pollack H . Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017; 376(7):605-607. DOI: 10.1056/NEJMp1615145. View

Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014; 145:48-68. DOI: 10.1016/j.drugalcdep.2014.10.012. View

10.

Frenk S, Porter K, Paulozzi L . Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015; (189):1-8. View

11.

Jones C, Logan J, Gladden R, Bohm M . Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015; 64(26):719-25. PMC: 4584844. View

12.

Mars S, Bourgois P, Karandinos G, Montero F, Ciccarone D . "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy. 2013; 25(2):257-66. PMC: 3961517. DOI: 10.1016/j.drugpo.2013.10.004. View

13.

Dart R, Surratt H, Cicero T, Parrino M, Severtson S, Bucher-Bartelson B . Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015; 372(3):241-8. DOI: 10.1056/NEJMsa1406143. View

14.

Unick G, Rosenblum D, Mars S, Ciccarone D . Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013; 8(2):e54496. PMC: 3566161. DOI: 10.1371/journal.pone.0054496. View

15.

Banerjee G, Edelman E, Barry D, Becker W, Cerda M, Crystal S . Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction. 2016; 111(11):2021-2031. PMC: 5056813. DOI: 10.1111/add.13491. View

16.

Ciccarone D, Ondocsin J, Mars S . Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'. Int J Drug Policy. 2017; 46:146-155. PMC: 5577861. DOI: 10.1016/j.drugpo.2017.06.004. View

17.

Goldsamt L, Harocopos A, Kobrak P, Jost J, Clatts M . Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010; 35(3):258-67. PMC: 2862985. DOI: 10.1007/s10900-010-9231-z. View

18.

Martins S, Sarvet A, Santaella-Tenorio J, Saha T, Grant B, Hasin D . Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017; 74(5):445-455. PMC: 5470460. DOI: 10.1001/jamapsychiatry.2017.0113. View

19.

Unick G, Rosenblum D, Mars S, Ciccarone D . The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008. Addiction. 2014; 109(11):1889-98. PMC: 5725335. DOI: 10.1111/add.12664. View

20.

Cicero T, Ellis M, Surratt H, Kurtz S . The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014; 71(7):821-6. DOI: 10.1001/jamapsychiatry.2014.366. View